Lichen planopilaris (LPP)
January 2023
TLDR Treat active lichen planopilaris early to prevent permanent hair loss.
The document focused on the management of lichen planopilaris (LPP), a skin disease that significantly impacted quality of life and posed challenges in treatment, especially when initial therapies failed. It aimed to equip dermatology trainees and junior doctors with essential information and treatment options for LPP. The primary goal was to treat active disease to prevent further hair loss, as scarred areas were typically irreversible. Indicators of active disease included symptoms like itching, pain, burning, perifollicular hyperkeratosis, perifollicular erythema, ongoing hair loss, and biopsy results. The document recommended considering a tapering course of oral steroids (0.5–1 mg/kg) to stabilize active disease.